News
Announcement
Patient Story
Living Proof: Cancer Vaccine Recipients Bring Their Stories to Capitol Hill
June 4, 2026
Our Impact
Patient Story
A Legacy of Service: How One Woman’s Journey Could Help Bring a New Day for Pancreatic Cancer Patients
November 12, 2020
News Coverage
Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy
October 30, 2020
News Coverage
Blood Test Could Predict the Best Type of Treatment for Metastatic Melanoma
October 28, 2020
News Coverage
Putting AI in R&D
October 27, 2020
Cancer Research Heroes
Our Impact
Investing in People: The Power and Promise of High-Risk Science
October 22, 2020
News Coverage
The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement.
October 20, 2020
News Coverage
Hematology/oncology institutions, practices announce faculty promotions, additions
October 12, 2020
News Coverage
Parker Institute summoned the neoantigen pioneers to compare their prediction algorithms. And they have some suggestions for the field
October 9, 2020
Announcement
Our Impact
Press Release
Research Update
An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer
October 9, 2020